News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mazzo David J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| Mazzo David J (CEO) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,030 shares
@ $3.2, valued at
$3.3k
|
|
| 01/11/2023 |
4
| Mazzo David J (CEO) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 60,000 shares
@ $0
Paid exercise price by delivering 7,845 shares
@ $3, valued at
$23.5k
Paid exercise price by delivering 3,470 shares
@ $3.195, valued at
$11.1k
Granted 30,000 options to buy
@ $3, valued at
$90k
|
|
| 01/18/2022 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Paid exercise price by delivering 6,471 shares
@ $0.8063, valued at
$5.2k
Paid exercise price by delivering 6,611 shares
@ $0.8204, valued at
$5.4k
|
|
| 01/12/2022 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 401,000 shares
@ $0
Paid exercise price by delivering 56,410 shares
@ $0.917, valued at
$51.7k
Paid exercise price by delivering 16,740 shares
@ $0.8651, valued at
$14.5k
Granted 200,000 options to buy
@ $0.917, valued at
$183.4k
|
|
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2020 |
4
| Mazzo David J (Director) has filed a Form 4 on Seneca Biopharma, Inc.|
Txns:
| Granted 6,000 options to buy
@ $0 |
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 46,000 shares
@ $0
Paid exercise price by delivering 6,246 shares
@ $3.28, valued at
$20.5k
Paid exercise price by delivering 6,382 shares
@ $3.38, valued at
$21.6k
Granted 69,000 options to buy
@ $3.28, valued at
$226.3k
|
|
| 01/09/2020 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Paid exercise price by delivering 4,522 shares
@ $2.83, valued at
$12.8k
|
|
| 10/11/2019 |
4/A
| Mazzo David J (Director) has filed a Form 4 on Neuralstem, Inc.|
Txns:
| Granted 10,106 options to buy
@ $0 |
|
| 10/11/2019 |
4
| Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 33,333 options to buy
@ $1.95, valued at
$65k
|
|
| 09/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Mazzo David J (Director) has filed a Form 4 on Neuralstem, Inc.|
Txns:
| Granted 187,510 options to buy
@ $0.3001, valued at
$56.3k
|
|
| 06/27/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2019 |
4
| Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 20,000 options to buy
@ $1.77, valued at
$35.4k
|
|
| 01/16/2019 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 47,000 shares
@ $0
Paid exercise price by delivering 6,301 shares
@ $0
Granted 71,000 options to buy
@ $4.95, valued at
$351.5k
|
|
| 01/10/2019 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Paid exercise price by delivering 4,478 shares
@ $4.64, valued at
$20.8k
|
|
| 09/10/2018 |
4
| Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 1,667 options to buy
@ $2.32, valued at
$3.9k
Granted 417 restricted stock units
@ $0 |
|
| 06/29/2018 |
4
| Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 17,500 restricted stock units
@ $0 |
|
| 06/26/2018 |
4
| Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 33,333 options to buy
@ $1.95, valued at
$65k
Granted 8,333 restricted stock units
@ $0 |
|
| 06/21/2018 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 33,300 shares
@ $8.64, valued at
$287.7k
Paid exercise price by delivering 16,091 shares
@ $8.64, valued at
$139k
|
|
| 04/24/2018 |
4
| Mazzo David J (Director) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Exercised 120,000 options to buy
@ $1.13, valued at
$135.6k
|
|
| 04/10/2018 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 33,300 options to buy
@ $0 |
|
| 01/10/2018 |
4
| Mazzo David J (CEO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 33,300 shares
@ $0
Paid exercise price by delivering 4,462 shares
@ $0
Granted 50,000 options
@ $3.79, valued at
$189.5k
|
|
| 12/19/2017 |
4
| Mazzo David J (Director) has filed a Form 4 on pSivida Corp.|
Txns:
| Granted 20,000 options to buy
@ $1.77, valued at
$35.4k
Granted 17,500 restricted stock units
@ $0 |
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|